Mellen Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA
Robert A BermelMellen Center, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA
Carrie M HershLou Ruvo Center for Brain Health, Cleveland Clinic, Las Vegas, NV, USA
Megan HylandDepartment of Neurology, University of Rochester Medical Center, Rochester, NY, USA
Ellen M MowryDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Robert NaismithDepartment of Neurology, Washington University in St. Louis, St. Louis, MO, USA
Jacqueline NicholasOhioHealth Multiple Sclerosis Center, Riverside Methodist Hospital, Columbus, OH, USA
Mar TintorèCentre d’Esclerosi Múltiple de Catalunya, Department of Neurology and Neuroimmunology, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
Ana ZabalzaCentre d’Esclerosi Múltiple de Catalunya, Department of Neurology and Neuroimmunology, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
Tjalf ZiemssenMultiple Sclerosis Center Dresden, Center of Clinical Neuroscience, Department of Neurology, University Clinic Carl-Gustav Carus, Dresden, Germany
Xavier MontalbanCentre d’Esclerosi Múltiple de Catalunya, Department of Neurology and Neuroimmunology, Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain
on behalf of the MS PATHS Investigators*M.L.N. and R.R. were employees of Biogen at the time the analysis was conducted.
Corresponding Author:JA Cohen Mellen Center, Neurological Institute, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA. [email protected]
Comments (0)